Shots:
- The P-I/II study of AZD1222 has resumed in Japan following the discussion with the PMDA. Additionally, the company is in talks with the US FDA to facilitate review of the information needed to decide regarding the resumption of the US trial
- A standard review process triggered a voluntary pause to vaccination across all global trials on Sept 06, 2020, to allow the review of safety data by an independent committee
- The resumption follows the restart of clinical study in the UK, Brazil, South Africa, and India
Click here to read full press release/ article | Ref: AstraZeneca | Image: Mint
Related News: AstraZeneca Resumes COVID-19 Vaccine Trials in the UK
The post AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan first appeared on PharmaShots.
